On 11 April 2020, the United States Pharmacopeia (USP) issued guidance regarding operational considerations during the COVID-19 pandemic. These instructions include assignment of beyond use dates, certifications, and cleaning/disinfecting. The Joint Commission (TJC) has issued declared that "(o)rganizations may utilize these guidelines and remain in compliance with Joint Commission standards until the state of emergency has been lifted at the regional, state or national level."
top of page
(980) 236-8290
Search
Recent Posts
See AllThe FDA has now finalized the 2024 guidance for 510(k) information required for sterilization of reusable medical devices with some...
This article begins to highlight the need for effective contract performance documentation and evaluation. You must place specific,...
Post: Blog2_Post
bottom of page
Comentários